AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug

In an exchange filing, the pharma firm said the Central Drugs Standard Control Organisation gave its node for import for sale and distribution of durvalumab solution for infusion 120mg/2.4ml and 500mg/10ml.

Leave a Reply

Your email address will not be published. Required fields are marked *